Director of the Rutgers Center for Tobacco Studies and a professor of Health Behavior, Cristine Delnevo has accepted the position of chairperson of the U.S. Food and Drug Administration’s (FDA) Tobacco Products Scientific Advisory Committee (TPSAC).
Delnevo was appointed in March 2021, and she will hold the position until January 2025. TPSAC is in charge of reviewing and evaluating the safety and health risks of tobacco products and releases information and recommendations to the FDA’s commissioner accordingly.
The committee members are selected from among people with expertise in the fields of medicine, science or technology involving the manufacture and use of tobacco products.
“I have valued the importance of this FDA advisory committee since the signing of the Family Smoking Prevention and Tobacco Control Act in 2009,” said Delnevo. “This advisory committee plays an important role in several ways, perhaps most notably on the review of modified risk tobacco product applications, as required under the Tobacco Control Act. I value the service of Dr. Jonathan Samet and Dr. Robin Mermelstein who served admirably before me as chair, and I look forward to working with an esteemed group of colleagues to help the FDA make regulatory decisions to protect public health and reduce tobacco-related morbidity and mortality.”
Diane Caruana – VapingPost – 2022-08-11.
Want More Investigative Content?
